Abstract
This review focuses on the different modes of expression of the epidermal growth factor receptor (EGFR). All methods used to assess EGFR expression are critically analyzed and insights into the use of inhibitors of EGFR for treatment of cervical cancer are discussed. Currently, expression of EGFR as a biomarker for prognosis or for treatment of cervical cancer is not defined for clinical use. © The Author 2011. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Soonthornthum, T., Arias-pulido, H., Joste, N., Lomo, L., Muller, C., Rutledge, T., & Verschraegen, C. (2011). Epidermal growth factor receptor as a biomarker for cervical cancer. Annals of Oncology. Oxford University Press. https://doi.org/10.1093/annonc/mdq723
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
